Sufferers of psychotic illnesses ‘may have treatable immune disorder’
Scientists at University of Oxford find up to one in 11 cases of psychosis may involve condition where antibodies attack the brain
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Some sufferers of psychotic illnesses like schizophrenia may have a treatable immune disorder, research suggests.
In a nationwide study, scientists at the University of Oxford found up to one in 11 cases of psychosis may involve a condition where antibodies attack the brain.
The team suggested that all patients displaying signs of psychosis for the first time should be screened for the antibodies to see if alternative treatments may be possible.
The study, published in The Lancet, was led by Professor Belinda Lennox, a clinical psychiatrist at the University of Oxford.
She told the BBC: “The implications of this are that there are patients in mental health services now who will have these antibodies and could potentially be treated in a very different way.
“I think this is a really exciting advance for psychiatry as a whole, and every psychiatrist and patient with psychosis needs to be aware of this and to look for it and treat it assertively when we find it.”
Analysis of blood samples from 228 people found 9% had antibodies that might be relevant to their illness.
However some are doubtful that there are large numbers of patients in institutions who have been misdiagnosed.
Josep Dalmau, from the University of Barcelona, told the BBC: “The large majority of patients develop other symptoms, for example seizures or abnormal movements.
“These usually bring the diagnosis to the doctors, so I think (considering) the number of patients you may have in a psychiatric institution with well-established psychotic disorder for several months or years, the likelihood they have these antibodies is extremely low.”
PA
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments